- Correction 30 March 2022
Will Omicron finally overpower China’s COVID defences?
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Rent or buy this article
Get just this article for as long as you need it
Prices may be subject to local taxes which are calculated during checkout
Nature 604, 17-18 (2022)
Updates & Corrections
Correction 30 March 2022: An earlier version of this story incorrectly attributed the rates of vaccination in people over 80 on the Chinese mainland to an Airfinity report rather than the Chinese government. This has been corrected.
McMenamin, E. et al. Preprint at medRxiv https://doi.org/10.1101/2022.03.22.22272769 (2022).